SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3661 167 0
Emcee:  dalroi Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3161Four doozies today: PTIE, DRRX, SRPT, AKBA. Is that a record?DewDiligence_on_SI110/27/2014
3160ADHD, down to $4.30 off 25% Piper Jaffray analyst Charles Duncan slashed his prThe Ox-10/23/2014
3159TKMR -15% Ebola related stocks are losing some of their inflated value. CMRX alstnsaf-10/20/2014
3158and rightly so I believe.mopgcw-10/9/2014
3157ARWR -42% Adam Feurstein drops the blame on management's heads thestreet.comtnsaf-10/9/2014
3156That news probably explains most of ADHD's decline last week.tnsaf-10/6/2014
3155SNSS -78%; ADHD -57%—both from failed failed-3 trials: finance.yahoo.com silicDewDiligence_on_SI-10/6/2014
3154ADHD: I would suspect there is a financing coming soon, but in June they said thtnsaf-10/2/2014
3153ADHD -17%, recovering to -13% at end of trading, resuming its strong decline afttnsaf-10/2/2014
3152ADHD -18% on 4X ADV; no precipitous drop, just a slow decline over the day. Jittnsaf-9/30/2014
3151EXEL—Percentage drop unknown at this point, but it will likely be large: siliconDewDiligence_on_SI-9/1/2014
3150RGDO -50% in pre-market trading on termination of phase-3 trial, which effectiveDewDiligence_on_SI-8/25/2014
3149onty 17% on EMR 63325-009 failure and wedbush downgrade. fwiw, not at buy levelmopgcw-8/19/2014
3148TKMR — MOMO-up crowd is now the MOMO-down crowd. Nice hat shaped chart for the ltnsaf-8/12/2014
3147RNA -16% on planned secondary offering (in the formal sense): siliconinvestor.coDewDiligence_on_SI-7/7/2014
3146RGDO -56% on unplanned halt of phase-3 trial for safety: siliconinvestor.comDewDiligence_on_SI-7/3/2014
3145TKMR 16% VANCOUVER, British Columbia, July 3, 2014 (GLOBE NEWSWIRE) -- Tekmira nigel bates-7/3/2014
3144NWBO down about 20% on 4x Avg Volume Due to this thestreet.comJohn McCarthy-6/19/2014
3143ECYT 16% WEST LAFAYETTE, Ind., June 17, 2014 (GLOBE NEWSWIRE) -- Endocyte, Inc.nigel bates-6/18/2014
3142ARWR -17% on no news that I can findtnsaf-6/13/2014
3141Orexigen (OREX) off 17% after FDA announces three month extension on decision. tuck-6/11/2014
3140EXAS is barely up today, which suggests that most investors didn't consider DewDiligence_on_SI-6/3/2014
3139CLVS -15%, continuing its fall from yesterday; hit 52 week lowtnsaf-6/3/2014
3138Epigenomics 40%: Berlin (Germany) and Germantown, MD (U.S.A.), June 2, 2014 - Enigel bates-6/3/2014
3137Re: BLUE: turns out EHA is having some kind of technical glitch, and abstracts tuck-5/21/2014
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News